Clinical Trial Update: A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is exploring a short treatment regimen for rifampicin-resistant, isoniazid-susceptible pulmonary tuberculosis; the study status is NOT_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Tuberculosis, Pulmonary | Phase 3 | Status: NOT_YET_RECRUITING